TwinBeech Capital’s Gilead Sciences GILD Stock Holding History

TwinBeech Capital’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$535K	Buy	+4,231	New	+$557K	0.1%	220
2026 Q1	–	Sell	-12,978	Closed	-$1.59M	–	678
2025 Q4	$1.59M	Sell	12,978 -11,360	-47%	-$1.38M	0.11%	228
2025 Q3	$2.7M	Buy	+24,338	New	+$2.77M	0.11%	197
2024 Q1	–	Sell	-179,078	Closed	-$14.5M	–	676
2023 Q4	$14.5M	Buy	+179,078	New	+$13.9M	0.23%	129
2023 Q3	–	Sell	-280,569	Closed	-$21.6M	–	736
2023 Q2	$21.6M	Buy	+280,569	New	+$22.4M	0.43%	69
2022 Q1	–	Sell	-3,110	Closed	-$226K	–	593
2021 Q4	$226K	Buy	+3,110	New	+$214K	0.01%	509
2021 Q1	–	Sell	-18,516	Closed	-$1.08M	–	528
2020 Q4	$1.08M	Buy	+18,516	New	+$1.12M	0.18%	167
2020 Q1	–	Sell	-35,961	Closed	-$2.34M	–	364
2019 Q4	$2.34M	Buy	+35,961	New	+$2.34M	0.68%	34

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TwinBeech Capital's GILD Position: Q2 2026 in Review

TwinBeech Capital opened a new position in Gilead Sciences (GILD) in Q2 2026: 4,231 shares worth $535K. The stake represents 0.1% of the portfolio and ranks #220 among its holdings. This is a return to the name: TwinBeech Capital previously reported a position in GILD as recently as Q4 2025.

TwinBeech Capital first reported a position in GILD in Q4 2019 and has held it in 8 quarters since. The position peaked at $21.6M in Q2 2023. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

TwinBeech Capital held 4,231 shares of Gilead Sciences worth $535K as of Q2 2026.
Gilead Sciences was a new TwinBeech Capital position in Q2 2026.
Gilead Sciences made up 0.1% of TwinBeech Capital's portfolio in Q2 2026, its #220 holding.
TwinBeech Capital first reported a position in Gilead Sciences in Q4 2019 and has held it in 8 quarters since.
TwinBeech Capital's Gilead Sciences position peaked at $21.6M in Q2 2023.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on TwinBeech Capital's 13F filing for Q2 2026, filed 14 Aug 2026.